 |
Articles: Drug Trials |
Prior Articles
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
Pharmacoepidemiology and Drug Safety, 10/27/09
Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer
Bristol Myers-Squibb Company, 10/26/09
Free full text
Interim Clinical Trial Results Show MedImmunes H1N1 Vaccine Has Similar Safety Profile as Seasonal Vaccine in Eligible Children and Adults
Medimmune, 10/23/09
Free full text
Medtronic Highlights Positive ONSET Pediatric Diabetes Trial Results
Medtronic, 10/23/09
Free full text
GlaxoSmithKline and Human Genome Sciences announce full presentation at ACR of positive phase 3 study results for BENLYSTA in systemic lupus erythematosus
GlaxoSmithKline, 10/21/09
Free full text
Teva Comments On Positive Results Of Phase III Trial In Mediwound's Debrase
Teva Pharmaceutical Industries, 10/21/09
Free full text
First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease
Genzyme, 10/21/09
Free full text
Novartis drug Tasigna meets primary endpoint in pivotal trial against Glivec as first-line treatment in chronic myeloid leukemia patients
Novartis, 10/21/09
Free full text
Enriched Enrollment Randomized Withdrawal Trial Designs of Analgesics: Focus on Methodology
The Clinical Journal of Pain, 10/21/09 CEL-SCI To Commence First Clinical Study With Hospitalized H1N1 Infected Patients
CEL-SCI, 10/21/09 Leading Dengue and TB scientists discuss new clinical research approaches and models of excellence for clinical research and trials in endemic regions
Novartis, 10/20/09
Free full text
Repligen Announces Completion of Patient Treatment in Phase 3 Clinical Trial of RG1068 in MRI Imaging of the Pancreas
Repligen, 10/20/09
Free full text
XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease
XenoPort, 10/20/09 Pandemic 2009 Influenza Update: Results from second clinical trial of GSKs H1N1 adjuvanted vaccine confirm immune response and tolerability
GlaxoSmithKline, 10/19/09
Free full text
Phase I Biodistribution and Pharmacokinetic Study of Lewis Y–Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers
Clinical Cancer Research, 10/19/09 Forest Laboratories and Cypress Bioscience Announce Study Shows Patients Treated with Savella Experience Improvements in Pain and Physical Function
Forest Laboratories, 10/19/09
Free full text
Human genome sciences to host november 2nd conference call to discuss top-line results from second phase 3 trial of benlysta (belimumab) in systemic lupus erythematosus
Human Genome Sciences, 10/16/09
Free full text
Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials
Journal of Pharmacy and Pharmacology, 10/15/09 MediGene successfully completes patient recruitment into EndoTAG(TM)-1 Phase II breast cancer trial
MediGene, 10/12/09
Free full text
Panenza and Humenza Influenza A(H1N1) Vaccines Demonstrate Robust Immune Response After One Dose
Sanofi-aventis, 10/09/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
